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Background
A randomized, double-blind, placebo-controlled study
was performed to evaluate the effects of oral BCAA and
leucine supplementation on the ERK1/2 MAP Kinase sig-
nal transduction pathway in conjunction with an acute
bout of lower-body resistance exercise (RE).
Methods
30 males (22.5 yrs; 81.1 kg) ingested either leucine (60
mg/kg/bw), BCAA (120 mg/kg/bw), or placebo. Supple-
mentation was ingested at 3 time points (1/3 of the total
dosage at each time point): 30 minutes prior to RE, and
immediately pre- and post-RE. The subjects performed 4
sets of leg press and leg extension at 80% 1 RM to failure.
Rest periods between sets and exercises were approx. 150
seconds. Muscle biopsies (via the Bergstrom technique)
were obtained from the vastus lateralis at four time points:
baseline and 30 min, 2 hrs, and 6 hrs post RE and sampled
for MEK1 and ERK1/2 activation (via phosphoELISA kits).
Participants were fasted for the duration of the investiga-
tional period. Other variables (serum markers and other
skeletal muscle proteins) were analyzed as part of a larger
investigation, but only MEK1 and ERK1/2 and their acti-
vation/phosphorylation state are presented here. Skeletal
muscle variables (MEK1 and ERK1/2) were transformed
to delta values and analyzed via a 3 (group) × 4 (time
points) repeated measures MANOVA. Univariate ANO-
VAs (Bonferroni adjusted) were conducted as follow-up
tests to the MANOVA. Post-hoc tests of the interaction
effects demonstrated in the ANOVA were investigated via
an independent samples T-test.
Results
There was a main effect for time for MEK1 at the 2 hr time
point (p = .005). No main effect for group or a group ×
time interaction was observed for MEK1. Relative to
ERK1/2, there were no main effects for time. A main effect
for group revealed that the BCAA supplementation signif-
icantly elevated ERK1/2 activation as compared to the leu-
cine (p = .001) and placebo groups (p = .001). A group ×
time interaction revealed that BCAA supplementation sig-
nificantly elevated ERK1/2 activation at the 2 hr post and
6 hr post time points in comparison with the Leucine (p =
.045) and placebo groups (p < .001).
Conclusion
BCAA supplementation increased the phosphorylation
status of ERK1/2 in conjunction with RE at 2 and 6 hours
post-exercise. Leucine supplementation did not have any
effect on ERK1/2 activation.
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